Report #2848930

Received Jul 8, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (1)

Product administered at inappropriate site

Symptom narrative

i have taken first dose of Shingrix at buttock; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of vaccine administered at inappropriate site in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccine administered at inappropriate site (Verbatim: i have taken first dose of Shingrix at buttock). The outcome of the vaccine administered at inappropriate site was not applicable. Additional Information: GSK Receipt Date: 28-JUN-2025 This case was reported by a patient via interactive digital media. The reporter reported that have taken first dose of Shingrix at buttock which led to vaccine administered at inappropriate site. The reporter asked was it ok.